3-hydroxybutyric acid has been researched along with donepezil in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, L; Fu, J; Guo, C; Huang, J; Huo, Y; Lu, J; Wan, L; Xin, B; Yang, Q; Zhong, Y | 1 |
Gureviciene, I; Jin, N; Tanila, H; Ziyatdinova, S | 1 |
2 other study(ies) available for 3-hydroxybutyric acid and donepezil
Article | Year |
---|---|
Acetylcholinesterase Inhibitor Donepezil Effects on Plasma β-Hydroxybutyrate Levels in the Treatment of Alzheimer's Disease.
Topics: 3-Hydroxybutyric Acid; Aged; Aged, 80 and over; Alzheimer Disease; Animals; Blood Glucose; Cholesterol; Cholinesterase Inhibitors; Cross-Sectional Studies; Donepezil; Fasting; Fatty Acids; Female; Gas Chromatography-Mass Spectrometry; Gene Expression Regulation; Humans; Hydroxymethylglutaryl-CoA Synthase; Ketone Bodies; Male; Mice; Mice, Inbred ICR; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Time Factors | 2018 |
Response of spike-wave discharges in aged APP/PS1 Alzheimer model mice to antiepileptic, metabolic and cholinergic drugs.
Topics: 3-Hydroxybutyric Acid; Action Potentials; Alzheimer Disease; Animals; Anticonvulsants; Atropine; Disease Models, Animal; Donepezil; Drug Administration Schedule; Electroencephalography; Epilepsy; Ethosuximide; GABA Antagonists; Humans; Injections, Intraperitoneal; Lactic Acid; Levetiracetam; Male; Mice; Mice, Transgenic; Nootropic Agents; Organophosphorus Compounds; Parasympatholytics; Plaque, Amyloid; Pyruvic Acid; Video Recording | 2020 |